{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:08:41Z","timestamp":1791248921343,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trop Dis Travel Med Vaccines"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Ocular tuberculosis (TB) affects 1\u20132% of patients with TB, with TB uveitis being the most common. This series aims to look at different manifestations of tuberculosis associated uveitis and the different tests used to make a presumptive or definitive diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients diagnosed with TB related uveitis in Hong Kong SAR between 2017 and 2020 were reviewed. Demographics, clinical features, investigations and treatments of patients were collected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fifteen eyes in 10 patients with a mean age 57.30\u2009\u00b1\u200910.17 years were included. The ocular manifestations on presentation included anterior uveitis (50%), posterior uveitis (40%) and panuveitis (10%), where 70% of them were unilateral and 30% were bilaterally infected; on subsequent visits the manifestations further developed into posterior uveitis (40%), panuveitis (40%) and anterior uveitis (20%), where 50% of them were unilateral and 50% bilateral infected. Tuberculosis tests were positive in 5 out of 7 Mantoux tests, 4 out of 4 T-SPOT TB tests, 3 out of 4 QuantiFERON-TB gold tests, 1 out of 1 lymph node biopsy, 0 out of 9 chest x-rays, and no aqueous fluid polymerase chain reaction (PCR) was tested. Vision impairing complications were seen in 6 patients where retinal vasculitis was most commonly seen. With anti-TB treatment prescribed in 9 patients, side effects occurred in 5 patients, including ocular hypertension, disc swelling, and hepatitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Ocular TB infections may manifest in various forms, and can involve different parts of the eye. Bilateral involvement of TB is commonly presented, and both eyes should be evaluated at every follow up. When TB is suspected in a patient, diagnostic confirmation requires multimodal investigations where a negative chest x-ray is not useful in ruling out ocular TB infections, especially in an endemic region like Hong Kong. In these patients, it is crucial to have a high index of suspicion for TB, even when they do not demonstrate classical respiratory signs and symptoms of TB.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40794-023-00205-w","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T19:03:49Z","timestamp":1699988629000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Ocular manifestations and diagnosis of tuberculosis involving the uvea: a case series"],"prefix":"10.1186","volume":"9","author":[{"given":"Jennifer KS","family":"Tsui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie Hiu Ling","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas Siu Kay","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,15]]},"reference":[{"key":"205_CR1","unstructured":"World Health Organisation (WHO) GTP. Global tuberculosis report 2022. In: Organisation WH, ed., 2022."},{"key":"205_CR2","unstructured":"Global tuberculosis report. 2019. In: Organization WH, ed., 2019."},{"key":"205_CR3","unstructured":"Elimination DoT. The Difference Between Latent TB Infection and TB Disease. In: (CDC) CfDCaP, ed., 2014."},{"key":"205_CR4","doi-asserted-by":"crossref","unstructured":"Alastair KO, Denniston PIM. Oxford Handbook of Ophthalmology: Oxford University Press 2018.","DOI":"10.1093\/med\/9780198804550.001.0001"},{"issue":"5","key":"205_CR5","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/eye.2012.1","volume":"26","author":"M Ang","year":"2012","unstructured":"Ang M, Wong W, Ngan C, et al. Interferon-gamma release assay as a diagnostic test for tuberculosis-associated uveitis. Eye. 2012;26(5):658\u201365.","journal-title":"Eye"},{"issue":"9","key":"205_CR6","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/sj.eye.6702093","volume":"20","author":"D Varma","year":"2006","unstructured":"Varma D, Anand S, Reddy A, et al. Tuberculosis: an under-diagnosed aetiological agent in uveitis with an effective treatment. Eye. 2006;20(9):1068\u201373.","journal-title":"Eye"},{"issue":"6","key":"205_CR7","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.survophthal.2007.08.015","volume":"52","author":"V Gupta","year":"2007","unstructured":"Gupta V, Gupta A, Rao NA. Intraocular tuberculosis\u2013an update. Surv Ophthalmol. 2007;52(6):561\u201387. https:\/\/doi.org\/10.1016\/j.survophthal.2007.08.015. [published Online First: 2007\/11\/22].","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"205_CR8","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/ceo.12881","volume":"45","author":"KK Ng","year":"2017","unstructured":"Ng KK, Nisbet M, Damato EM, et al. Presumed tuberculous uveitis in non-endemic country for tuberculosis: case series from a New Zealand tertiary uveitis clinic. Clin Exp Ophthalmol. 2017;45(4):357\u201365. https:\/\/doi.org\/10.1111\/ceo.12881. [published Online First: 2016\/11\/30].","journal-title":"Clin Exp Ophthalmol"},{"issue":"5","key":"205_CR9","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.revmed.2018.02.014","volume":"39","author":"M Koubaa","year":"2018","unstructured":"Koubaa M, Smaoui F, Gargouri S, et al. [Ocular tuberculosis: a case series]. Rev Med Interne. 2018;39(5):326\u201331. https:\/\/doi.org\/10.1016\/j.revmed.2018.02.014. [published Online First: 2018\/03\/28].","journal-title":"Rev Med Interne"},{"key":"205_CR10","unstructured":"Sujata Prabhu M, Julie H, Tsai A, Palestine MD, Jennifer Cao MD, Julie H, Tsai M, Al-Falah MD, Al-Falah M, Read RW. MD, PhD. Tuberculosis Uveitis, 2020."},{"issue":"5","key":"205_CR11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3109\/09273940903168688","volume":"17","author":"DV Vasconcelos-Santos","year":"2009","unstructured":"Vasconcelos-Santos DV, Zierhut M, Rao NA. Strengths and weaknesses of diagnostic tools for tuberculous uveitis. Ocul Immunol Inflamm. 2009;17(5):351\u20135. https:\/\/doi.org\/10.3109\/09273940903168688. [published Online First: 2009\/10\/17].","journal-title":"Ocul Immunol Inflamm"},{"key":"205_CR12","unstructured":"Elimination DoT. Tuberculin Skin Test. In: (CDC) CfDCaP, ed., 2020."},{"issue":"4 Pt 2","key":"205_CR13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1164\/ajrccm.161.supplement_3.ats600","volume":"161","author":"Targeted tuberculin testing and treatment of latent tuberculosis infection","year":"2000","unstructured":"Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the american thoracic society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the american thoracic society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med. 2000;161(4 Pt 2):221\u201347. https:\/\/doi.org\/10.1164\/ajrccm.161.supplement_3.ats600. [published Online First: 2000\/04\/14].","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"205_CR14","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1164\/rccm.200509-1516PP","volume":"174","author":"L Richeldi","year":"2006","unstructured":"Richeldi L. An update on the diagnosis of tuberculosis infection. Am J Respir Crit Care Med. 2006;174(7):736\u201342. https:\/\/doi.org\/10.1164\/rccm.200509-1516PP. [published Online First: 2006\/06\/27].","journal-title":"Am J Respir Crit Care Med"},{"key":"205_CR15","unstructured":"Interferon-Gamma Release Assays. (IGRAs) \u2013 Blood Tests for TB Infection. In: Prevention CfDCa, ed., 2016."},{"issue":"7551","key":"205_CR16","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1136\/bmj.332.7551.1194","volume":"332","author":"IA Campbell","year":"2006","unstructured":"Campbell IA, Bah-Sow O. Pulmonary tuberculosis: diagnosis and treatment. BMJ. 2006;332(7551):1194\u201397.","journal-title":"BMJ"},{"issue":"3","key":"205_CR17","doi-asserted-by":"publisher","first-page":"B","DOI":"10.2471\/blt.07.043802","volume":"86","author":"N Awofeso","year":"2008","unstructured":"Awofeso N. Anti-tuberculosis medication side-effects constitute major factor for poor adherence to tuberculosis treatment. Bull World Health Organ. 2008;86(3):B\u2013D. https:\/\/doi.org\/10.2471\/blt.07.043802.","journal-title":"Bull World Health Organ"},{"issue":"1","key":"205_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1148\/rg.2017160032","volume":"37","author":"AC Nachiappan","year":"2017","unstructured":"Nachiappan AC, Rahbar K, Shi X, et al. Pulmonary tuberculosis: role of Radiology in diagnosis and management. Radiographics. 2017;37(1):52\u201372. https:\/\/doi.org\/10.1148\/rg.2017160032.","journal-title":"Radiographics"},{"issue":"1","key":"205_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4103\/2229-5178.93479","volume":"3","author":"S Nayak","year":"2012","unstructured":"Nayak S, Acharjya B. Mantoux test and its interpretation. Indian Dermatol Online J. 2012;3(1):2\u20136. https:\/\/doi.org\/10.4103\/2229-5178.93479.","journal-title":"Indian Dermatol Online J"},{"issue":"2","key":"205_CR20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1128\/jcm.32.2.277-284.1994","volume":"32","author":"GT Noordhoek","year":"1994","unstructured":"Noordhoek GT, Kolk AH, Bjune G, et al. Sensitivity and specificity of PCR for detection of Mycobacterium tuberculosis: a blind comparison study among seven laboratories. J Clin Microbiol. 1994;32(2):277\u201384. https:\/\/doi.org\/10.1128\/jcm.32.2.277-284.1994. [published Online First: 1994\/02\/01].","journal-title":"J Clin Microbiol"},{"key":"205_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1746-1596-3-37","volume":"3","author":"SJ Drews","year":"2008","unstructured":"Drews SJ, Eshaghi A, Pyskir D, et al. The relative test performance characteristics of two commercial assays for the detection of Mycobacterium tuberculosis complex in paraffin-fixed human biopsy specimens. Diagn Pathol. 2008;3:37. https:\/\/doi.org\/10.1186\/1746-1596-3-37. [published Online First: 2008\/09\/10].","journal-title":"Diagn Pathol"},{"issue":"1","key":"205_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1869-5760-3-25","volume":"3","author":"K Sharma","year":"2013","unstructured":"Sharma K, Gupta V, Bansal R, et al. Novel multi-targeted polymerase chain reaction for diagnosis of presumed tubercular uveitis. J Ophthalmic Inflamm Infect. 2013;3(1):25\u20135. https:\/\/doi.org\/10.1186\/1869-5760-3-25.","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"4","key":"205_CR23","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/eye.2013.11","volume":"27","author":"K Manousaridis","year":"2013","unstructured":"Manousaridis K, Ong E, Stenton C, et al. Clinical presentation, treatment, and outcomes in presumed intraocular tuberculosis: experience from Newcastle upon Tyne, UK. Eye. 2013;27(4):480\u20136. https:\/\/doi.org\/10.1038\/eye.2013.11. [published Online First: 2013\/02\/23].","journal-title":"Eye"},{"issue":"5","key":"205_CR24","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.ajo.2008.06.011","volume":"146","author":"R Bansal","year":"2008","unstructured":"Bansal R, Gupta A, Gupta V, et al. Role of anti-tubercular therapy in uveitis with latent\/manifest tuberculosis. Am J Ophthalmol. 2008;146(5):772\u20139. https:\/\/doi.org\/10.1016\/j.ajo.2008.06.011. [published Online First: 2008\/08\/19].","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"205_CR25","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/sj.eye.6702093","volume":"20","author":"D Varma","year":"2006","unstructured":"Varma D, Anand S, Reddy AR, et al. Tuberculosis: an under-diagnosed aetiological agent in uveitis with an effective treatment. Eye (London England. 2006;20(9):1068\u201373. https:\/\/doi.org\/10.1038\/sj.eye.6702093. [published Online First: 2005\/10\/11].","journal-title":"Eye (London England"},{"issue":"4","key":"205_CR26","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/eye.2010.235","volume":"25","author":"C Sanghvi","year":"2011","unstructured":"Sanghvi C, Bell C, Woodhead M, et al. Presumed tuberculous uveitis: diagnosis, management, and outcome. Eye. 2011;25(4):475\u201380. https:\/\/doi.org\/10.1038\/eye.2010.235. [published Online First: 2011\/02\/05].","journal-title":"Eye"},{"key":"205_CR27","doi-asserted-by":"publisher","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005;140(3):509 \u2013 16. https:\/\/doi.org\/10.1016\/j.ajo.2005.03.057 [published Online First: 2005\/10\/01].","DOI":"10.1016\/j.ajo.2005.03.057"}],"container-title":["Tropical Diseases, Travel Medicine and Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40794-023-00205-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40794-023-00205-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40794-023-00205-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T01:37:55Z","timestamp":1700271475000},"score":1,"resource":{"primary":{"URL":"https:\/\/tdtmvjournal.biomedcentral.com\/articles\/10.1186\/s40794-023-00205-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,15]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["205"],"URL":"https:\/\/doi.org\/10.1186\/s40794-023-00205-w","relation":{},"ISSN":["2055-0936"],"issn-type":[{"value":"2055-0936","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,15]]},"assertion":[{"value":"22 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol followed the principles of the Declaration of Helsinki and was approved by the Institutional Review Board (IRB) of The University of Hong Kong \/ Hospital Authority Hong Kong West Cluster HKU\/HA HKW (IRB ref. UW22-549). Consent to participate was obtained from all participants and\/or relatives of deceased patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent to publish this case has not been obtained. This report does not contain any personal identifying information.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"20"}}